Title: |
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology |
Source: |
Journal of Medicinal Chemistry
[0022-2623]
Beaufils,
Florent
yr:2017
|
|
|
|